Mirtazapine Mega Study
Contents
Mirtazapine
Mirtazapine

Related

A
Milligrams
A
Treatments
A
Effects
A
User Variables 19
A
Measurements 200

Tags

Mirtazapine

Treatment Effectiveness

User reported effectiveness ratings Mirtazapine for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Depression 13% 31% 13% 31% 11% 61
Irritable Bowel Syndrome 0% 0% 50% 50% 0% 4
Anxiety 4% 30% 19% 26% 22% 27

Below is the degree of change seen after Mirtazapine is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Mirtazapine Info

Property Value
Variable Name Mirtazapine
Aggregation Method SUM
Analysis Performed At 2021-07-16
Duration of Action 21 days
Filling Value 0
Kurtosis 50.914137622936
Mean 12.055902727273 milligrams
Median 11.545454545455 milligrams
Minimum Allowed Value 0 milligrams
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 187
Number of Measurements 200
Number of Measurements (including those generated by tagged, joined, or child variables) 1850
Public true
Onset Delay 30 minutes
Standard Deviation 4.9966465407534
Unit Milligrams
User Variables 19
UPC 035127699356
Variable Category Treatments
Variable ID 1378
Variance 56.509386548245